Optimal Timing of Ketamine Initiation for SCD Pain

Clinical trial NCT07450430 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07450430
Sponsor: Boston Children's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Crisis

Start date: 2026-02-01
Primary completion: 2029-02-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.